Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002783.SZ Stock Summary
Top 10 Correlated ETFs
002783.SZ
In the News
002783.SZ Financial details
Company Rating
Strong Buy
Market Cap
3.1B
Income
138.32M
Revenue
3.63B
Book val./share
4.08
Cash/share
1.42
Dividend
0.1
Dividend %
0.98%
Employees
3.85K
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
30.23
Forward P/E
-
PEG
-2.35
P/S
1.07
P/B
2.68
P/C
5.49
P/FCF
-13.4
Quick Ratio
0.52
Current Ratio
0.64
Debt / Equity
1.7
LT Debt / Equity
0.31
-
-
EPS (TTM)
0.36
EPS next Y
-
EPS next Q
-
EPS this Y
-127.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
7.84%
Revenue last 5Y
12.8%
Revenue Q/Q
8.14%
EPS Q/Q
-31.82%
-
-
-
-
SMA20
-11.11%
SMA50
-11.11%
SMA100
-20%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
9%
ROC
0.06%
Gross Margin
27%
Oper. Margin
6%
Profit Margin
4%
Payout
104%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.14-12.75
52W High
-35%
52W Low
+30%
RSI
28
Rel Volume
1.19
Avg Volume
12.41M
Volume
14.74M
Perf Week
-7.03%
Perf Month
-10.34%
Perf Quarter
-5.8%
Perf Half Y
-8.56%
-
-
-
-
Beta
0.589
-
-
Volatility
0.43%, 0.44%
Prev Close
10.01%
Price
7.8
Change
1.04%
002783.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.59 | 5.3 | 5.32 | 7.18 | 8.92 | |
Net income per share | 0.24 | 0.32 | 0.25 | -1.27 | 0.35 | |
Operating cash flow per share | 0.71 | 0.79 | 0.26 | 0.03 | 0.69 | |
Free cash flow per share | -0.27 | -0.92 | -0.49 | -0.65 | 0.07 | |
Cash per share | 3.33 | 2.37 | 2.36 | 1.63 | 2.62 | |
Book value per share | 4.52 | 4.8 | 4.55 | 3.37 | 3.76 | |
Tangible book value per share | 4.45 | 5.14 | 4.87 | 3.62 | 4.12 | |
Share holders equity per share | 4.52 | 4.8 | 4.55 | 3.37 | 3.76 | |
Interest debt per share | 3.78 | 3.84 | 6.39 | 6.64 | 7.52 | |
Market cap | 2.07B | 4.2B | 3.8B | 4.12B | 3.24B | |
Enterprise value | 2.17B | 4.97B | 5.29B | 5.99B | 4.98B | |
P/E ratio | 25.34 | 37.11 | 40.57 | -8.46 | 24.3 | |
Price to sales ratio | 1.11 | 2.22 | 1.89 | 1.5 | 0.95 | |
POCF ratio | 8.78 | 14.92 | 38.54 | 425.74 | 12.34 | |
PFCF ratio | -22.81 | -12.8 | -20.34 | -16.52 | 114.92 | |
P/B Ratio | 1.37 | 2.45 | 2.21 | 3.19 | 2.26 | |
PTB ratio | 1.37 | 2.45 | 2.21 | 3.19 | 2.26 | |
EV to sales | 1.16 | 2.63 | 2.63 | 2.18 | 1.46 | |
Enterprise value over EBITDA | 5.92 | 11.5 | 11.38 | 14.89 | 7.7 | |
EV to operating cash flow | 9.19 | 17.66 | 53.74 | 619.48 | 18.97 | |
EV to free cash flow | -23.87 | -15.16 | -28.37 | -24.04 | 176.71 | |
Earnings yield | 0.04 | 0.03 | 0.02 | -0.12 | 0.04 | |
Free cash flow yield | -0.04 | -0.08 | -0.05 | -0.06 | 0.01 | |
Debt to equity | 0.81 | 0.77 | 1.35 | 1.87 | 1.91 | |
Debt to assets | 0.32 | 0.3 | 0.35 | 0.35 | 0.37 | |
Net debt to EBITDA | 0.26 | 1.79 | 3.22 | 4.66 | 2.69 | |
Current ratio | 1.97 | 1.24 | 0.65 | 0.6 | 0.63 | |
Interest coverage | 5.31 | 5.55 | 3.28 | 0.84 | 2.63 | |
Income quality | 1.79 | 2.49 | 1.05 | -0.02 | 1.69 | |
Dividend Yield | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | |
Payout ratio | 0.86 | 0.98 | 1.19 | -0.35 | 0.7 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 | |
Intangibles to total assets | 0.12 | 0.09 | 0.12 | 0.1 | 0.09 | |
Capex to operating cash flow | -1.38 | -2.17 | -2.89 | -26.76 | -0.89 | |
Capex to revenue | -0.18 | -0.32 | -0.14 | -0.09 | -0.07 | |
Capex to depreciation | -2.81 | -3.7 | -1.47 | -0.87 | -0.81 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.02 | 0 | |
Graham number | 4.99 | 5.85 | 5.04 | 9.84 | 5.44 | |
ROIC | 0.05 | 0.06 | 0.05 | 0.03 | 0.07 | |
Return on tangible assets | 0.02 | 0.03 | 0.02 | -0.08 | 0.02 | |
Graham Net | -1.14 | -2.74 | -6.73 | -8.35 | -8.26 | |
Working capital | 838.44M | 293.69M | -1.04B | -1.36B | -1.51B | |
Tangible asset value | 1.49B | 1.84B | 1.84B | 1.38B | 1.57B | |
Net current asset value | -166.52M | -683.91M | -2.16B | -2.72B | -2.63B | |
Invested capital | 0.81 | 0.77 | 1.35 | 1.87 | 1.91 | |
Average receivables | 364.48M | 380.58M | 525.98M | 858.56M | 1.1B | |
Average payables | 173.05M | 323.31M | 667.32M | 926.26M | 1.01B | |
Average inventory | 149.59M | 169.2M | 199.31M | 258.8M | 333.53M | |
Days sales outstanding | 75.5 | 72.44 | 122.81 | 138.55 | 123.46 | |
Days payables outstanding | 69.5 | 125.25 | 231.4 | 160.46 | 152.6 | |
Days of inventory on hand | 52.43 | 49.01 | 59.56 | 48.34 | 54.52 | |
Receivables turnover | 4.83 | 5.04 | 2.97 | 2.63 | 2.96 | |
Payables turnover | 5.25 | 2.91 | 1.58 | 2.27 | 2.39 | |
Inventory turnover | 6.96 | 7.45 | 6.13 | 7.55 | 6.69 | |
ROE | 0.05 | 0.07 | 0.05 | -0.38 | 0.09 | |
Capex per share | -0.98 | -1.71 | -0.75 | -0.68 | -0.61 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.25 | 2.4 | 2.05 | 2.43 | 2.63 | |
Net income per share | 0.1 | -0.08 | 0.08 | 0.22 | 0.15 | |
Operating cash flow per share | 0.1 | -0.08 | 0.08 | 0.35 | 0.21 | |
Free cash flow per share | -0.05 | -0.28 | -0.51 | -0.01 | 0.03 | |
Cash per share | 2.04 | 2.62 | 2.03 | 1.73 | 1.42 | |
Book value per share | 3.82 | 3.76 | 3.85 | 3.95 | 4.08 | |
Tangible book value per share | 4.2 | 4.12 | 3.9 | 3.98 | 3.72 | |
Share holders equity per share | 3.82 | 3.76 | 3.85 | 3.95 | 4.08 | |
Interest debt per share | 6.53 | 7.26 | 7.13 | 7.36 | 7.02 | |
Market cap | 3.17B | 3.24B | 3.42B | 3.18B | 3.24B | |
Enterprise value | 4.94B | 4.98B | 5.37B | 5.31B | 5.35B | |
P/E ratio | 20.77 | -25.82 | 29.1 | 9.63 | 14.04 | |
Price to sales ratio | 3.69 | 3.53 | 4.36 | 3.43 | 3.23 | |
POCF ratio | 83.07 | -103.29 | 116.4 | 24.16 | 40.42 | |
PFCF ratio | -151.74 | -30.7 | -17.65 | -1.03K | 252.16 | |
P/B Ratio | 2.18 | 2.26 | 2.32 | 2.11 | 2.08 | |
PTB ratio | 2.18 | 2.26 | 2.32 | 2.11 | 2.08 | |
EV to sales | 5.74 | 5.44 | 6.85 | 5.73 | 5.34 | |
Enterprise value over EBITDA | 47.36 | 62.59 | 64.9 | 32.78 | 40.28 | |
EV to operating cash flow | 129.24 | -158.82 | 183 | 40.28 | 66.78 | |
EV to free cash flow | -236.07 | -47.21 | -27.74 | -1.72K | 416.66 | |
Earnings yield | 0.01 | -0.01 | 0.01 | 0.03 | 0.02 | |
Free cash flow yield | -0.01 | -0.03 | -0.06 | 0 | 0 | |
Debt to equity | 1.69 | 1.91 | 1.83 | 1.84 | 1.7 | |
Debt to assets | 0.33 | 0.37 | 0.36 | 0.38 | 0.35 | |
Net debt to EBITDA | 16.92 | 21.89 | 23.62 | 13.12 | 15.9 | |
Current ratio | 0.66 | 0.63 | 0.57 | 0.59 | 0.64 | |
Interest coverage | 2.8 | -1 | 1.13 | 3.84 | 3.25 | |
Income quality | 1 | 1 | 1 | 1.59 | 1.39 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0.02 | 0.01 | |
Payout ratio | 0.67 | -0.19 | 1.09 | 0.78 | 0.7 | |
Sales general and administrative to revenue | 0.24 | -0.19 | 0.09 | -0.05 | 0.23 | |
Research and developement to revenue | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.09 | 0.09 | 0.12 | 0.12 | 0.14 | |
Capex to operating cash flow | -1.55 | 2.36 | -7.6 | -1.02 | -0.84 | |
Capex to revenue | -0.07 | -0.08 | -0.28 | -0.15 | -0.07 | |
Capex to depreciation | -0.74 | -0.92 | -2.65 | -1.6 | 0.41 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | -0.01 | |
Graham number | 2.93 | 2.64 | 2.58 | 4.39 | 3.73 | |
ROIC | 0.02 | -0.01 | 0.01 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0 | 0 | 0.01 | 0.01 | |
Graham Net | -8.4 | -8.26 | -8.37 | -8.35 | -8.5 | |
Working capital | -1.34B | -1.51B | -1.76B | -1.6B | -1.35B | |
Tangible asset value | 1.6B | 1.57B | 1.49B | 1.52B | 1.42B | |
Net current asset value | -2.61B | -2.63B | -2.66B | -2.66B | -2.65B | |
Invested capital | 1.69 | 1.91 | 1.83 | 1.84 | 1.7 | |
Average receivables | 1.33B | 1.29B | 1.14B | 1.18B | 1.33B | |
Average payables | 1.09B | 1.12B | 1.02B | 941.63M | 971.4M | |
Average inventory | 356.07M | 386.98M | 411.5M | 412.28M | 388.74M | |
Days sales outstanding | 148.65 | 113.09 | 129.82 | 118.5 | 128.36 | |
Days payables outstanding | 166.13 | 134.62 | 145.15 | 134.11 | 125.57 | |
Days of inventory on hand | 55.84 | 48.09 | 66.57 | 55.88 | 48.34 | |
Receivables turnover | 0.61 | 0.8 | 0.69 | 0.76 | 0.7 | |
Payables turnover | 0.54 | 0.67 | 0.62 | 0.67 | 0.72 | |
Inventory turnover | 1.61 | 1.87 | 1.35 | 1.61 | 1.86 | |
ROE | 0.03 | -0.02 | 0.02 | 0.05 | 0.04 | |
Capex per share | -0.15 | -0.19 | -0.58 | -0.35 | -0.18 |
002783.SZ Frequently Asked Questions
What is Hubei Kailong Chemical Group Co., Ltd. stock symbol ?
Hubei Kailong Chemical Group Co., Ltd. is a CN stock and trading under the symbol 002783.SZ
What is Hubei Kailong Chemical Group Co., Ltd. stock quote today ?
Hubei Kailong Chemical Group Co., Ltd. stock price is $7.8 today.
Is Hubei Kailong Chemical Group Co., Ltd. stock public?
Yes, Hubei Kailong Chemical Group Co., Ltd. is a publicly traded company.